NovoCure Limited ($NVCR)
Filing Information
| Accession Number | 0002039078-26-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 5, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
159,741
Total Value
$667,213.54
P&L
+inf% (+$1,340,083.08)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Ordinary Shares | โ | Mar 3, 2026 | Grant/Award | 45,112 | $0.00 | $0.00 | 121,455 | Direct | โ | View Details | |
Chief Operating Officer | Ordinary Shares | โ | Mar 4, 2026 | Sale | 5,377 | $13.31 | $71,543.14 | 116,078 | Direct | โ | View Details | |
Chief Operating Officer | Ordinary Shares | โ | Mar 5, 2026 | Sale | 43,246 | $13.77 | $595,670.40 | 72,832 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 3, 2026 | Grant/Award | 7,518 | $0.00 | $0.00 | 7,518 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Mar 3, 2026 | Grant/Award | 58,488 | $0.00 | $0.00 | 66,006 | Direct | โ | View Details |